Industry
Global Clinical Immunoanalyzers Market to Be Driven by High Incidence of Chronic and Infectious Diseases
The global clinical immunoanalyzers market has been witnessing high demand due to the high prevalence and incidence rates of chronic and infectious diseases, rapid growth in the elderly population, strong economic growth in the emerging markets, decline in oil prices, and health insurance reforms globally. However, low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes have been hampering market growth. More...28 Dec 2021
Global Point-of-Care Molecular Diagnostics Market to Be Driven by Rising Instances of Infectious Diseases
The global market for point-of-care (PoC) molecular diagnostics is predicted to record a solid growth over the next couple of years due to a rise in instances of infectious diseases and increasing public awareness about pre-disease detection. Additionally, growing research and development due to increased funding by both government and private entities, leading to new and better products being rolled out, will also have a positive impact on the market. More...27 Dec 2021
Quidel Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
Quidel Corporation (San Diego, CA, USA) and Ortho Clinical Diagnostics (Raritan, NJ, USA) have entered into a definitive agreement in which Quidel will acquire Ortho, one of the world’s largest in vitro diagnostics companies. More...24 Dec 2021
Clinical Laboratory Tests Market Driven by Demand for Molecular, Pathological and Immunological Testing
The global clinical laboratory tests market is expected to surpass USD 327 billion by 2028, driven by a growing geriatric population and increasing molecular, pathological, and immunological tests. More...17 Dec 2021
Global In-Vitro Diagnostics (IVD) Market to Surpass USD 115 Billion in 2028 Due to Increasing COVID-19 Test Volumes
The global in-vitro diagnostics (IVD) market is expected to reach USD 117.54 billion in 2028, driven by a rise in geriatric population worldwide, growing awareness of regular body profiling, surging prevalence of chronic diseases such as cancer and diabetes, and increasing sales of over-the-counter diagnostic devices such as glucose monitoring kits. More...14 Dec 2021
Global POC Diagnostics Market to Reach Nearly USD 90 Billion Due to Growing Demand for Rapid COVID-19 Test Kits
The global point of care (POC) diagnostics market is estimated to grow at a CAGR of 12.7% from approximately USD 36 billion in 2021 to nearly USD 90 billion in 2028, driven by the increasing prevalence of infectious diseases, product developments and launches, and rise in the number of CLIA-waived POC tests. However, product recalls are expected to hamper market growth. More...13 Dec 2021
Eurofins Acquires Genetic Lab Co. to Enhance Clinical and COVID-19 Testing Offering in Japan
Eurofins Scientific (Ebersberg, Germany) has entered into an agreement to acquire Genetic Lab Co., Ltd. (Japan), a molecular biology based testing provider for diagnostics, biomarker development and drug discovery. More...13 Dec 2021
Gold Member
Troponin T QC
Troponin T Quality Control
New
Malaria Rapid Test
OnSite Malaria Pf/Pan Ag Rapid Test
New
Tabletop Centrifuge
Mikro 185
In Other News
Global Point-of-Care Coagulation Testing Market to Be Driven by Growing Geriatric Population
Global HBA1c Laboratory Tests Market Driven by Rise in Diabetic Population
Roche Completes Acquisition of TIB Molbiol Group
Siemens Partners with Biotech Company Freenome to Develop Blood Test for Early Breast Cancer Detection
Global Lateral Flow Assay Market to Reach Nearly USD 6.5 Billion by 2031 Due to Surge in Demand for Rapid POC Testing
Global Chemiluminescence Immunoassay (CLIA) Analyzers Market to Surpass USD 7.5 Billion by 2025
Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases
Euromedlab Congress 2021 Postponed as Fourth COVID-19 Wave Hits Germany
MEDICA 2021 + COMPAMED 2021 Re-Launches In-Person with Innovations Galore for Outpatient and Inpatient Care
Blood Borne Testing Market to Witness Exponential Growth Due to Rising Incidence of Bacterial Infections
Rapid Medical Diagnostic Kits Market to Top USD 23 Billion by 2031 due to Successive Outbreaks of Novel Contagious Viruses
Global qPCR Instruments Market to Touch USD 1.4 Billion by 2028 on Back of Spike in COVID-19 Infections
Global Point-of-Care (POC) Testing Market to Reach Nearly USD 80 Billion by 2028 due to Increasing Dominance of Infectious Diseases
Certest Offers Real-Time PCR Assays for Fast Detection of MDR Bacterial Infections
Global Digital Polymerase Chain Reaction (dPCR) Market Projected to Reach Close to USD 1.15 Billion by 2028
Mesa Laboratories to Acquire Molecular Diagnostics Tools Company Agena Bioscience
Global Blood, Gas and Electrolyte Analyzers Market Projected to Reach Nearly USD 3.5 Billion by 2023
Global In Vitro Diagnostics (IVD) Quality Control Market Projected to Reach USD 1.4 Billion by 2026
Global COVID-19 Saliva-Based Screening Market to Continue Growing Due to Ease of Use and Shorter Test-to-Result
Global Hematology Testing Instrument Market Driven by Growing Demand for Preventive Diagnosis and Treatment Monitoring
Global Urinalysis Market Projected to Reach Nearly USD 5 Billion by 2026
Novel Artificial Intelligence (AI) Blood Test Can Detect Over 90% of Lung Cancers
Global Point of Care Diagnostics Market Expected to Reach USD 71 Billion in 2027
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.